Skip to content
Get random post
Saturday, March 14 2026
Health Herald
Health Herald
  • Home
  • Pharma
  • News
  • Pakistan
  • World
  • Health
  • Home Remedy
  • Contact US
  • Home
  • Pharma
  • News
  • Pakistan
  • World
  • Health
  • Home Remedy
  • Contact US

Tag: drug development partnership

News Pharma World

Boryung Corp. Signs CDMO Deal with Lotus Pharma for Anticancer Injection Production

  • Post Author By Health Herald
  • Post Date December 12, 2024
  • Post Comment 0 comments

Boryung Corp., a leading South Korean pharmaceutical company, has secured a strategic partnership with Lotus Pharmaceutical, a Taiwanese oncology specialist, to manufacture anticancer injections under […]

Tagged anticancer drug production, anticancer injection, Boryung Corp., Boryung manufacturing, CDMO agreement, cytotoxic drugs, drug development partnership, drug news, EU-GMP certification, Lotus Pharma, Novo Nordisk Engineering, oncology collaboration, oncology drugs, Pharma News, pharmaceutical manufacturing, South Korea, TaiwanLeave a Comment on Boryung Corp. Signs CDMO Deal with Lotus Pharma for Anticancer Injection Production

You May Also Like:

Urgent Alarm Over Paediatric TB Medicine Shortage in Pakistan

Pakistan Faces Critical Shortage of Paediatric TB Medicines The Pakistan Medical Association (PMA) has sounded an urgent alarm over the critical shortage of paediatric tuberculosis […]

Mpox Cases Rising in Pakistan: Health Authorities on Alert

Pakistan Faces Growing Concerns Over Mpox Transmission Public health emergencies often begin quietly, and Pakistan may now be entering such a phase with mpox. Over […]

Escalating Strikes in Lebanon Raise Humanitarian Concerns

Israeli Airstrike in Lebanon Kills 12 Medics Amid Escalating Conflict Southern Lebanon witnessed a devastating Israeli airstrike that killed 12 medical staff at a clinic […]

AI Is Redefining the Future of Research Labs

AI Revolutionizes the Modern R&D Lab The design of research and development labs is undergoing a dramatic shift as artificial intelligence and automation become central […]

Rare Disease Drug Sales to Exceed $400 Billion by 2032

Rare Disease Drugs Drive Pharma Growth Despite Challenges The rare disease drug market is on track for remarkable expansion, with global sales expected to surpass […]

Patent Expirations Set Biopharma on a Tough Path for 2026

Biopharma Faces a Critical Year Ahead The biopharma industry is entering 2026 with uncertainty, as patent expirations on blockbuster drugs are expected to reshape the […]

Copyright © 2023–2024 Healthherald.pk
Scroll to top